Medical University of Vienna

🇦🇹Austria

Country: 🇦🇹Austria

Ownership: Private

Established: 1365-01-01

Employees: 1K

Market Cap: -

Website: http://www.meduniwien.ac.at

Clinical Trials

Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients

Phase 4

Terminated

Conditions: Actinic Keratoses

Interventions: Other: photodynamic therapy
Drug: imiquimod 5% cream

First Posted Date: 2012-02-24

Last Posted Date: 2017-09-12

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 10

Registration Number: NCT01538901

Locations: 🇦🇹
Medical University of Vienna, University Clinic of Dermatology, Vienna, Austria
🇦🇹
Medical University of Vienna, Vienna, Austria

Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis

Phase 4

Completed

Conditions: Osteoporosis

Interventions: Drug: teriparatide
Drug: teriparatide and raloxifene
Drug: teriparatide and alendronate

First Posted Date: 2012-02-17

Last Posted Date: 2013-01-03

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 125

Registration Number: NCT01535027

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery

Phase 4

Completed

Conditions: Heart Failure
Acidosis, Lactic
Thiamine Deficiency

Interventions: Drug: Vitamin B1-ratiopharm
Drug: Placebo

First Posted Date: 2012-02-01

Last Posted Date: 2021-02-26

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 30

Registration Number: NCT01524315

Locations: 🇦🇹
Medical University Vienna, Vienna, Austria

Topical Local Anaesthesia and Cooling During Capsaicin 8% Patch Application

Completed

Conditions: Pain

First Posted Date: 2012-02-01

Last Posted Date: 2012-03-20

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 12

Registration Number: NCT01523951

Locations: 🇦🇹
Dept. of Spec. Anesthesia and Pain Therapy, Vienna, Austria

Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter Trial

Conditions: Breast Neoplasms

First Posted Date: 2012-02-01

Last Posted Date: 2012-02-01

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 600

Registration Number: NCT01524029

Locations: 🇦🇹
Medical University of Graz, Graz, Styria, Austria
🇦🇹
Kaiser Franz Josef Spital, Vienna, Austria
🇦🇹
Hanusch Krankenhaus, Vienna, Austria

and more 2 locations

Interventions to Prevent Adolescents With Type 1 Diabetes From Long-term Complications

Not Applicable

Conditions: Diabetes Mellitus, Type 1

Interventions: Behavioral: Motivational Interviewing, CBT and E-mail support

First Posted Date: 2012-01-30

Last Posted Date: 2012-09-27

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 120

Registration Number: NCT01520428

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis

Phase 2

Terminated

Conditions: Liver Cirrhosis
Hepatopulmonary Syndrome

Interventions: Drug: Placebo
Drug: bosentan

First Posted Date: 2012-01-26

Last Posted Date: 2016-09-28

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 6

Registration Number: NCT01518595

Locations: 🇦🇹
Medical University Vienna, Dpt. of Internal Medicine 3, Div. of Gastroenterology and Hepatology, Vienna, Austria

Additive Homeopathy in Cancer Patients

Phase 3

Completed

Conditions: Malignant Tumors

Interventions: Drug: Homeopathic Placebo globules
Drug: Additive classical homeopathy

First Posted Date: 2012-01-13

Last Posted Date: 2021-06-16

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 150

Registration Number: NCT01509612

Locations: 🇦🇹
Michael Frass, Wien, Austria

Morphological and Functional Evaluation of Irvine-Gass Syndrome

Completed

Conditions: Irvine Gass Syndrome

Interventions: Behavioral: if needed (decided individually) either Acular eye drops, Ultracortenol eye drop or intravitreal triamcinolone injection

First Posted Date: 2012-01-05

Last Posted Date: 2015-09-24

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 50

Registration Number: NCT01504074

Locations: 🇦🇹
Department of Ophthalmology Medical University of Vienna, Vienna, Austria

Photodynamic Therapy for Oral Precursor Lesions

Phase 3

Completed

Conditions: Leukoplakia
Lichen

Interventions: Other: Aminolaevulinic acid
Other: Methylcellulose Placebo

First Posted Date: 2011-12-23

Last Posted Date: 2017-05-17

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 28

Registration Number: NCT01497951

Locations: 🇦🇹
Bernhard Gottlieb University Clinic of Dentistry, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy